FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

Prof. Cursiefen re-elected to DFG Review Board

Claus Cursiefen

Professor Dr. Claus Cursiefen, Chairman of the Department of Ophthalmology of the University Hospital Cologne and Speaker of DFG FOR2240, has been re-elected to the DFG Review Board representing Ophthalmology . With him Professor Dr. Marius Ader from Regenerative Therapies Dresden, Technische Universität Dresden, Germany – CRTD Dresden received the most votes. Both have been elected to the Review Board DFG 206 representing ophthalmology within the section of neuroscience.

The DFG review boards evaluate proposals to fund research projects. They also monitor the review process to ensure that uniform standards are being observed. In addition they advise on issues concerning the further development and organisation of the DFG funding programmes. The work of the review boards is defined by the framework rules of procedure established by the DFG Senate, on the basis of which the 48 review boards draw up their own rules of procedure for the relevant membership period and elect a spokesperson and deputy spokesperson.

Members of the review boards are elected by researchers for four years in accordance with election regulations to be adopted by the Senate. They are assigned to a subject area according to the focus of their own research work. A group of subject areas that are scientifically linked form one review board. The structure of subject areas and review boards is re-examined by the Senate every four years as part of the preparations for the review board elections, and modified if necessary. A minimum of two representatives are selected for each subject area. The number of representatives per subject area also depends on how many funding proposals in that area require review and evaluation.

Related posts

January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more
November 22, 2022

4th Shanghai-Cologne Scientific Symposium


Read more

News

  • Rare eye diseases: Eight million euros for research: Funding for four years
  • Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface
  • Experimental Glaucoma Research Group awarded and funded
  • Leonhard Klein-Preis for Prof. Matthaei
  • 4th Shanghai-Cologne Scientific Symposium

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck